GB997176A - Anthranilic acid derivatives and process for their manufacture - Google Patents
Anthranilic acid derivatives and process for their manufactureInfo
- Publication number
- GB997176A GB997176A GB9620/63A GB962063A GB997176A GB 997176 A GB997176 A GB 997176A GB 9620/63 A GB9620/63 A GB 9620/63A GB 962063 A GB962063 A GB 962063A GB 997176 A GB997176 A GB 997176A
- Authority
- GB
- United Kingdom
- Prior art keywords
- salts
- group
- acids
- acid
- dimethylsulphamyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention comprises compounds of the formula <FORM:0997176/C2/1> wherein R1 is an amino group di-substituted by aliphatic hydrocarbon groups which may be interrupted by an oxygen, nitrogen or sulphur atom and/or may be substituted by a hydroxyl group, Ph represents a phenyl group, optionally bearing lower alkyl, hydroxy, acyloxy, lower alkoxy, methylenedioxy, nitro, amino, mono- or di-lower alkylamino, halogen or trifluoromethyl substituents, R1 represents hydrogen or a lower alkyl or acyl group and R represents hydrogen or a lower alkyl, lower alkoxy or trifluoromethyl group or a halogen atom (the word "lower" indicating a group of up to 7 carbon atoms), together with the corresponding salts, carboxylic esters and amides, and the compound 5-dimethylsulphamyl-2 -anilinobenzoic acid chloride. The acids, esters, anides and salts are made by (a) reacting a corresponding 2-halo-5-sulphamoyl benzoic acid or its ester or amide with an amine of the formula Ph.NH.R1 or (b) reacting a 2-anilino - 5 - sulphamoyl - benzoyl halide with water, an alcohol or a salt thereof, ammonia, or an amine; if desired, converting the resulting compound into a salt or converting a resulting salt into the free compound. Preferably, the substituents on the amino group R1 may be alkyl, e.g. methyl or ethyl, alkenyl, e.g. allyl or methallyl, hydroxyalkyl, e.g. hydroxyethyl or may combine to form an alkylene chain such as butylene, pentylene, hexylene or heptylene, which may be interrupted by hetero atoms to give corresponding oxa-, aza- or thia-alkylene chains. When the product is an ester, the esterifying group is suitably derived from an alkanol, cycloalknaol or a benzyl alcohol the phenyl radical of which may bear substituents as indicated above for the group Ph. When the product is a carboxylic amide, the amide nitrogen action may be mono- or di-substituted, e.g. by alkyl groups or may form part of a pyrrolidine, piperidine, piperazine, morpholine or thiamorpholine ring. Salts of the products include alkali and alkaline-earth metal salts of the acids and acid addition salts of those products which are basic with inorganic and organic acids, e.g. carboxylic and sulphonic acids, including inter alia p-aminosalicylic acid, methionine, tryptophan, lysine or arginine. 1 - Phenyl - 6 - dimethylsulphamyl - 2 - H - 3,1-benzoxazinone-(4) is made by condensing 5-dimethylsulphamoy 1-2-anilino-benzoic acid with formalin. 5 - Dimethylsulphamyl - 2,4 - dichlorobenzoic acid is made by treating 2,4-dichlorobenzoic acid-5 -sulphonyl chloride with dimethylamine. 5 - Dimethylsulphamyl - 2 - aniline - benzoic acid chloride is made by the action of thionyl chloride on the free acid. Pharmaceutical and veterinary preparations having anti-inflammatory, anti-pyretic, analgesic and anti-allergic properties comprise the above acids, esters or amides and their physiologically tolerable salts in admixture or conjunction with a pharmaceutically acceptable carrier. The preparations may take forms suitable for enteral, parenteral or local administration such as tablets, dragees, ointments, creams, solutions, suspensions, emulsions, or for veterinary use, animal feedstuff additives. The salts may be metal, ammonium or amine salts of the free acids, or addition salts with inorganic or organic acids, including ascorbic, salicylic and p-aminosalicylic acids, and methionine, tryptophan, lysine and arginine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH285262A CH433378A (en) | 1962-03-09 | 1962-03-09 | Process for the production of new anthranilic acid derivatives |
CH660362A CH452542A (en) | 1962-03-09 | 1962-05-30 | Process for the production of new anthranilic acid derivatives |
CH66363 | 1963-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB997176A true GB997176A (en) | 1965-07-07 |
Family
ID=27172288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9620/63A Expired GB997176A (en) | 1962-03-09 | 1963-03-11 | Anthranilic acid derivatives and process for their manufacture |
Country Status (4)
Country | Link |
---|---|
DE (1) | DE1493513C3 (en) |
ES (1) | ES285846A1 (en) |
FR (1) | FR2598M (en) |
GB (1) | GB997176A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5470882A (en) * | 1994-06-02 | 1995-11-28 | Smithkline Beecham Corp. | Anti-inflammatory compounds |
US5545669A (en) * | 1994-06-02 | 1996-08-13 | Adams; Jerry L. | Anti-inflammatory compounds |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH590261A5 (en) * | 1973-07-10 | 1977-07-29 | Ciba Geigy Ag |
-
1963
- 1963-03-02 DE DE1493513A patent/DE1493513C3/en not_active Expired
- 1963-03-08 ES ES285846A patent/ES285846A1/en not_active Expired
- 1963-03-11 GB GB9620/63A patent/GB997176A/en not_active Expired
- 1963-05-24 FR FR935806A patent/FR2598M/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5470882A (en) * | 1994-06-02 | 1995-11-28 | Smithkline Beecham Corp. | Anti-inflammatory compounds |
US5545669A (en) * | 1994-06-02 | 1996-08-13 | Adams; Jerry L. | Anti-inflammatory compounds |
US5912270A (en) * | 1994-06-02 | 1999-06-15 | Smithkline Beecham Corporation | Anti-inflammatory compounds |
Also Published As
Publication number | Publication date |
---|---|
ES285846A1 (en) | 1963-10-16 |
DE1493513C3 (en) | 1975-09-11 |
DE1493513A1 (en) | 1969-05-14 |
FR2598M (en) | 1964-06-15 |
DE1493513B2 (en) | 1975-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI912118A1 (en) | BENZIMIDAZOLONE DERIVATIVES | |
GB1069069A (en) | An aminoalkylethanoanthracene and process for its manufacture | |
ES359138A1 (en) | Acetylenic derivatives of 2-oxazolidinones and process of preparation | |
ES433890A1 (en) | PROCEDURE FOR THE PREPARATION OF NEW BENZYLAMINES. | |
GB1197479A (en) | 3,1-Benzoxazine Derivatives and Process for their Manufacture | |
GB1234699A (en) | Method of preparing substituted or unsubstituted 3-alkoxythianaphthene-2-carboxamides | |
ES359454A1 (en) | 2-anilino-nicotinic acid esters | |
GB997176A (en) | Anthranilic acid derivatives and process for their manufacture | |
GB1212460A (en) | Naphthacene derivatives | |
GB962293A (en) | New sydnonimines and process for their manufacture | |
IL37829A (en) | 2,4,6-triiodo-3-methylamino-benzoic acid derivatives | |
GB1061306A (en) | 4-substituted-2-benzhydryl-2-butanol derivatives | |
GB954196A (en) | Method of preparing amino esters | |
SU1187723A3 (en) | Method of producing hydrochloride of 2-oxymethyl-6-methyl-4-p-tolylthieno (2,3-c) piperidine | |
GB1114397A (en) | Novel diazahydrindanone and pyridopyrimidinone derivatives and a process for the manufacture thereof | |
GB1342321A (en) | Nitrofuran derivatives | |
GB1386206A (en) | Oxyacetic ether derivatives of orthothymotic esters their prepa ration and their applications | |
US3019245A (en) | Halo-disulfamylanilines | |
ES384946A1 (en) | Novel adamantylurea derivatives and a process for the preparation thereof | |
US3592902A (en) | Injection | |
GB1056046A (en) | Hydrocarbyl n-(aminoalkyl)-n-(2-aminophenyl) anthranilates | |
GB1292417A (en) | 4-amino-2-(5-nitro-2-thienyl) quinazolines, their preparation, and compositions containing them | |
GB1187514A (en) | New Substituted 2-Arylalkyloxy-Benzamides and the preparation thereof | |
GB1312392A (en) | Basically substituted 4 3h-quinazolinone derivatives and process for their manufacture | |
US3646137A (en) | Substituted toluidides and compositions containing them |